ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,624.97
      -0.16%
      US Tech 100
      20,081.15
      -0.19%
      Dow Jones
      39,838.20
      0.29%
      Brent Oil
      84.66
      -0.46%
      Bitcoin
      58,219.19
      0.80%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Fortrea Holdings Inc (FTRE) Quote

      Fortrea Holdings Inc

      Fortrea Holdings Inc (FTRE)

      NASDAQ
      24.405
      0.915
      ( 3.90% )
      Updated: 10:00:56
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      24.405
      Bid
      24.38
      Ask
      24.43
      Volume
      87,989
      23.61 Day's Range 24.46
      22.15 52 Week Range 41.02
      Market Cap
      2.1B
      Previous Close
      23.49
      Open
      23.88
      Last Trade
      20
      @
      24.41
      Last Trade Time
      10:01:00
      Financial Volume
      $ 2,119,928
      VWAP
      24.0931
      Average Volume (3m)
      1,414,962
      Shares Outstanding
      89,400,000
      Dividend Yield
      -
      PE Ratio
      -641.32
      Earnings Per Share (EPS)
      -0.04
      Revenue
      3.11B
      Net Profit
      -3.4M

      About Fortrea Holdings Inc

      Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, bio... Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina. Show more

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.fortrea.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Fortrea Holdings Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker FTRE. The last closing price for Fortrea was $23.49. Over the last year, Fortrea shares have traded in a share price range of $ 22.15 to $ 41.02.

      Fortrea currently has 89,400,000 shares outstanding. The market capitalization of Fortrea is $2.10 billion. Fortrea has a price to earnings ratio (PE ratio) of -641.32.

      FTRE Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

      2 hours ago

      Fortrea Appoints Robert Parks as Chief Accounting Officer

      DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Robert “Bobby” Parks has been appointed as...

      2 hours ago
      GlobeNewswire Inc.

      Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

      DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI...

      June 27 2024
      GlobeNewswire Inc.

      Fortrea to Participate in Virtual Fireside Chat with Evercore ISI

      DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will...

      June 19 2024
      GlobeNewswire Inc.

      Fortrea to Present at the Jefferies Global Healthcare Conference

      DURHAM, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike...

      June 03 2024
      GlobeNewswire Inc.

      Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

      DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated...

      May 30 2024
      GlobeNewswire Inc.

      Fortrea Appoints Machelle Sanders to Board of Directors

      DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the appointment of Machelle...

      May 16 2024
      GlobeNewswire Inc.

      U.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed Reactions

      U.S. index futures show an upward trend in Monday’s pre-market following the best week of the year for the Dow Jones. With Wall Street on alert, the market eagerly awaits the release of new...

      May 13 2024
      IH Market News

      Fortrea Reports First Quarter 2024 Results

      For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 millionGAAP net loss of $81.6 millionAdjusted EBITDA of $29.5 millionGAAP and adjusted diluted earnings...

      May 13 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.8653.6745964316123.5424.56522.68105954523.28779887CS
      4-0.405-1.6324062877924.8125.0722.15128119723.4624918CS
      12-11.975-32.916437603136.3838.03522.15141496227.73739259CS
      26-6.445-20.891410048630.8541.0222.15110125631.01707916CS
      52-5.895-19.455445544630.341.0222.15122123030.38933414CS
      156-9.395-27.795857988233.841.0222.15139945531.0539457CS
      260-9.395-27.795857988233.841.0222.15139945531.0539457CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KZIAKazia Therapeutics Ltd
      $ 1.28
      (91.56%)
      		101.07M
      LCFYLocafy Ltd
      $ 4.20
      (81.03%)
      		351.42k
      BDRXBiodexa Pharmaceuticals PLC
      $ 1.26
      (77.19%)
      		43.73M
      VLCNVolcon Inc
      $ 6.16
      (68.77%)
      		18.26M
      ISPCiSpecimen Inc
      $ 0.4801
      (67.93%)
      		18.98M
      CINGCingulate Inc
      $ 0.491
      (-24.23%)
      		670.07k
      CETUUCetus Capital Acquisition Corporation
      $ 7.58
      (-23.90%)
      		305
      IVPInspire Veterinary Partners Inc
      $ 5.84
      (-21.08%)
      		978.3k
      SLRXSalarius Pharmaceuticals Inc
      $ 2.23
      (-18.69%)
      		1.63M
      CLNNClene Inc
      $ 4.61
      (-17.97%)
      		31.61k
      KZIAKazia Therapeutics Ltd
      $ 1.27
      (90.06%)
      		101.08M
      RNLXRenalytix PLC
      $ 0.414
      (37.13%)
      		58.3M
      NVDANVIDIA Corporation
      $ 133.525
      (-1.03%)
      		55.17M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.19979
      (-5.22%)
      		54.73M
      BDRXBiodexa Pharmaceuticals PLC
      $ 1.26
      (77.19%)
      		43.73M

      Discussion

      View Full Feed
      TIMGZ TIMGZ 3 minutes ago
      HOW LOW WILL "BDRX" GO**** AVERAGING DOWN AND STILL HOLDING***MIGHT BOUNCE AND WOULDN'T BE SURPRISED IF IT TOUCHES $0.95
      BDRX
      Buddyboy20 Buddyboy20 3 minutes ago
      Misiu sent me a note and straightened me out. I apologize.
      CYDY
      Chartmaster Chartmaster 3 minutes ago
      Filled the gap open, support at 60, now we can go back up!
      SMCE
      ZRock ZRock 3 minutes ago
      keep undercutting the ask. grrrrrr
      KSCP
      JettaR JettaR 3 minutes ago
      Down 30% on 25k. Not so locked up. Nice dump before expert market hits.
      RGLG
      rack186 rack186 3 minutes ago
      Longs or fake longs ??
      ELTP
      wadegarret wadegarret 3 minutes ago
      updated

      PSIX 5000 shares

      GERN 43000 shares

      AAOI 14000 shares

      Cash negativde $1342
      GERN
      Real McCoy Real McCoy 3 minutes ago
      Clearly. You seem to want to talk about cosmetic attributes, which are not in dispute here at all, and I’d like to clear up the result of the liquidation, which have been meekly disputed. I also asked again for your thoughts on that dispute given your knowledge of the facts.
      jxyzobrien jxyzobrien 3 minutes ago
      not a happy family
      up move
      few things look good
      KILLAZILLA KILLAZILLA 3 minutes ago
      LOLOLOLOL....WHAT'S your DD SINCE you're NOW DOWN OVER 90% IN THIS POS SCAM!!!

      CHECK THE FINS. they(LYING GRIFTERS) ARE BROKE!!!
      WDLF
      glenn1919 glenn1919 3 minutes ago
      BIG......RCAT......STAF.......https://stockcharts.com/h-sc/ui?s=STAF&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=BIG&p=W&b=5&g=0&id=p84354014936
      https://stockcharts.com/h-sc/ui?s=RCAT&p=W&b=5&g=0&id=p84354014936
      RCAT STAF
      Swammmie1040 Swammmie1040 3 minutes ago
      Got 2 milly this morning lol badgers were everywhere yesterday . Emotional trading will get ya all the time, good luck ….
      RONN
      ducci1 ducci1 4 minutes ago
      Ridin 560P .40---let see !
      SPY
      getmoreshares getmoreshares 4 minutes ago
      IMO this will see .50 before EOY- possibly much higher.
      NSAV
      Noghawbuck Noghawbuck 4 minutes ago
      🫏 🫏 what happened to Virginia Beech you forget about it was going to open in two weeks wonder why stock is below a penny you forget about your great shareholders holding the bag , your the best guys for the job !
      FUNN
      ducci1 ducci1 4 minutes ago
      May be time to go down & visit Da pivot at 5618 ?
      SPY
      Hawk05 Hawk05 4 minutes ago
      That’s just awesome! I’m praying for the best for both shareholders and Team BIEL but with the limited info hard to just continue with blind faith.
      BIEL
      sunspotter sunspotter 4 minutes ago
      “ Jeff should speak in general terms and explain what potential benefits going EM can have for a company.”

      There are literally zero benefits for the company or its shareholders in being on the “expert” market.

      It does however allow “management” to operate in the shadows
      RSPI
      Filterthenoise Filterthenoise 4 minutes ago
      Do it!!Spring this! $RNVA
      RNVA
      Mufaso Mufaso 4 minutes ago
      "Just over four million people are expected to use GLP-1s this year, according to Needham analyst Mike Matson, who used National Library of Medicine data to reach his estimate."

      This quote appeared in an article about Resmed (a maker of CPAP machines) being a buying opportunity:
      GLP
      tdbowieknife tdbowieknife 5 minutes ago
      FINRA will have an issue with the fraudulent disclosure statements.

      Rule 6490(d)(3) lays out the conditions under which an SEA Rule 10b-17 Action or Other Company-Related Action may be considered deficient and hence may not be processed. The rule outlines several factors that FINRA co
      GRLT
      stockinspector stockinspector 5 minutes ago
      Keep in mind that the loudest knuckle draggers here bought in around .02 cents a share thinking they would steal the show. They were impatient then and more so today. Now all they can do is complain and try to make others miss their opportunity to grow.
      WDLF
      Filterthenoise Filterthenoise 5 minutes ago
      EM is overblown. But I wouldn't be shocked if next week starts the fun 🤞
      RNVA
      nicehit nicehit 5 minutes ago
      It makes no sense that it's been like this for decades.
      Bashers on the OTC is rampant! But I have to say, at times, they are right.

      99% of these stocks are BS and nothing but paper movers.

      Hopefully, NSAV is on the right track this time. We will see in the nex
      NSAV

      Your Recent History

      NASDAQ
      FTRE
      Fortrea
      Delayed Upgrade Clock